STUDresearch · Non-peptide

Telmisartan

Also known as

Micardis · telmi · ARB · telmisartan 20 · telmisartan 40 · telmisartan 80

Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.

Non-peptide Some talk Systemic Oral Longevity & cellular energy

Systemic oral angiotensin-II receptor blocker (ARB).

What people say A prescription oral angiotensin-II receptor blocker used for hypertension and cardiovascular-risk reduction in selected patients. It is a systemic blood-pressure drug, not a casual longevity supplement. Doses people talk about

Lower community/label-range amount20 mg orally once daily

Discussed in TRT/biohacking threads and within the labeled 20–80 mg range; not a universal starting amount.

Labeled hypertension start40 mg orally once daily

Typical label starting amount, with a 20–80 mg range based on clinical response.

Labeled ceiling80 mg orally once daily

Maximum once-daily labeled hypertension amount; not an escalation target for a person with normal pressure.

Rows compare labeled and reported amounts, not a progression. Baseline blood pressure, kidney function, potassium and co-medications materially change risk.

Half-life & effect duration

Half-life in the body: Label estimateAbout 24 hours
Healthy-volunteer study meansAbout 23–24 hours
Felt duration people report: Many accountsNo noticeable sensation
Other accountsDizziness or low blood-pressure readings, often with other compounds

Timing context & sources

How it may feel Often there is no distinct sensation; some report dizziness or hypotensive readings. Telmisartan threads frequently include tadalafil, TRT, taurine, citrulline, dehydration or heat, so symptom attribution is limited.

Cycles people discuss Clinical use is generally daily and open-ended with cuff and laboratory monitoring, not a short cycle. Blood pressure can move back toward baseline over days after stopping. Timing Once-daily oral use is ongoing rather than an eight-week cycle. Morning and night both appear in community notes; some pair morning use with tadalafil and watch for dizziness or low readings, while individual self-reports follow home-cuff trends across weeks. These are reported routines, not a preferred time of day. Stacks Tadalafil and other vasodilator or supplement combinations appear in TRT/longevity threads. Multiple blood-pressure-lowering agents can produce hypotension, and these reports do not establish a beneficial stack. Watch for Low BP / faint: Community reports discuss dizziness or fainting when telmisartan is combined with tadalafil, sauna use or a calorie deficit.

Tap a line to jump into the full notes. Research only — may be wrong.

Timing context & sources

Half-life in the body

Terminal plasma half-life is about 24 hours; a healthy-volunteer study reported mean values near 23 hours.

DailyMed reports a roughly 24-hour terminal half-life and 0.5–1-hour Tmax; it also says most antihypertensive effect is apparent within 2 weeks and maximal reduction is generally attained after 4 weeks. A study in 36 healthy Chinese men reported mean terminal half-lives of 23.6 and 23.0 hours after 40 and 80 mg.

Healthy-volunteer and label summaries; disease, hepatic function and interactions can alter exposure. Once-daily coverage does not mean constant subjective effect.

DailyMed telmisartan prescribing information (opens in a new tab)Clinical Pharmacology and Dosage sections: 0.5–1-hour Tmax, approximately 24-hour terminal half-life, once-daily 20–80 mg hypertension range, most antihypertensive effect apparent within 2 weeks, and maximal reduction generally attained after 4 weeks.Label data do not predict an individual felt response; contraindications, pregnancy warning and monitoring remain product-specific.
Pharmacokinetics of telmisartan in healthy Chinese volunteers (opens in a new tab)Abstract: 36 healthy men received 40 or 80 mg; mean terminal half-lives 23.6 ± 10.8 and 23.0 ± 6.4 hours, with Tmax 1.76 and 1.56 hours.Small healthy male study with high variability; not a clinical blood-pressure or subjective-duration trial.

Felt duration people report

No dependable felt-duration clock: many report no sensation, while dizziness and low readings depend on baseline pressure and co-exposures.

TRT threads include a 20 mg telmisartan plus 2.5 mg tadalafil user reporting 125/60 and a multi-agent user who stopped telmisartan after hypotensive episodes. Another author describes pre-TRT 20 mg use and later 40, 60 and 80 mg changes after TRT raised home readings; the author had only two days at 80 mg when posting.

Self-selected reports, home cuffs, dose changes and combinations with tadalafil, TRT, taurine or citrulline; no isolated symptom-duration estimate or prevalence.

Telmisartan and tadalafil blood-pressure report (opens in a new tab)Thread body and replies: 54-year-old author reports TRT-associated 150/90, then 20 mg telmisartan plus 2.5 mg tadalafil and readings around 125/60; discussion focuses on low diastolic pressure.Two active pressure-lowering drugs, TRT and home measurements; cannot isolate telmisartan or determine clinical appropriateness.
Hypotension during tadalafil/telmisartan supplement stack (opens in a new tab)Replies include a user combining tadalafil, telmisartan, taurine and citrulline who reported hypotensive episodes and stopped telmisartan; other authors discuss different responses.Multiple authors and simultaneous vasoactive agents; no verified readings, dose chronology or causal isolation.
Telmisartan dose and BP changes during TRT (opens in a new tab)Thread and replies: one author reports physician-prescribed 20 mg before TRT; after four weeks on TRT and higher home readings, the author describes subsequent 40, 60 and 80 mg use and had only two days at 80 mg when posting.TRT and serial dose changes, short follow-up at the highest amount, home cuff data and no controlled comparator.

What people say 5

Longevity / endothelial stack: Daily telmi as “background vessel care” next to tadalafil 5 mg in TRT logs. Confounded by everything else in the stack. forum
PPAR-γ / insulin-sensitivity lore: The reason it beat other ARBs in biohack ranking posts. Human metabolic outcome data is thinner than the BP trials. forum
BP control: 20–80 mg once daily is the labeled range; 40 mg start, 80 mg ceiling is the usual clinic titration. trial
Last-6-hour coverage vs losartan: Older head-to-heads people paste — telmi 40–80 held BP later in the dosing interval than losartan 50. trial
Stroke / CV-risk 80 mg talk: Label language for high-risk adults who cannot take an ACE inhibitor — not a DIY longevity protocol. trial

Doses people talk about 6

Biohack / “I’m 110/70 already” band: 20 mg daily, sometimes 40. The Attia-adjacent background dose in those posts. forum
Not split BID for most — long half-life is the point. trial
Framing: Labeled milligrams and forum microdoses — not a stack to copy. forum
Labeled start (HTN): 40 mg oral once daily; range 20–80 mg. trial
Labeled ceiling: 80 mg once daily. trial
CV-risk label talk: 80 mg once daily. trial

How it may feel 5

Days 1–7: Many people report no distinct sensation, while dizziness or low readings can occur, especially with tadalafil, TRT changes, dehydration or heat. Inspected threads included a 20 mg telmisartan plus 2.5 mg tadalafil report with 125/60 readings and another multi-agent user who stopped telmisartan after hypotensive episodes. forum
Weeks 2–4: Home-cuff logs are what careful n=1s actually watch. forum
If BP was never high: Longevity microdosers at 20 mg still report lightheadedness. anecdote
Stop: BP returns toward baseline over days; no “ARB withdrawal high” like clonidine lore. forum
Potassium / kidney labs: The unsexy month-1 story clinics actually run. trial

Cycles people discuss 4

Longevity n=1s also run it continuously and check cuffs, not “cycle off.” forum
Not interchangeable mL-for-mL with ACE inhibitors (cough vs ARB). forum
Daily, open-ended: BP drugs are not 8-week blasts. trial
Stop before surgery / volume depletion is clinic caution, not a forum cycle. trial

Timing 4

Morning vs night: Argued. Some put it with tadalafil AM and watch gym-faint. Others dose at night. forum
Half-life ~24 hours — why once daily covers the last 6 hours better than shorter ARBs in those comparisons. trial
Tmax ~0.5–1 hour; BP effect is not a 20-minute stimulant. trial
Bile / liver: Telmisartan is mostly fecal; kidney impairment is still a lab conversation because BP drugs plus NSAIDs plus dehydration is the stacked-risk story. trial

Stacks 5

Reported blood-pressure chronology: One reply describes physician-prescribed 20 mg telmisartan before TRT, followed by self-reported 40, 60 and 80 mg changes after TRT raised home readings; no other pressure-lowering drug was reported in that account. This is chronology, not a starting-dose or titration instruction. forum
+ Tadalafil 2.5–5 mg: The TRT “vessels” pair. Two BP-drop drugs. forum
+ Nattokinase / fish oil: CoffeeBlack-style cardio drawer — bleeding + BP watch. forum
+ NAC / TUDCA: Same longevity screenshot, unrelated mechanisms. forum
Not with a potassium-sparing experiment blindly. trial

Storage notes 2

Pharmacy tablets. Dry, original blister. forum
Not a peptide reconstitution. forum

Related 5

Watch for 6

Low BP / faint: Community reports discuss dizziness or fainting when telmisartan is combined with tadalafil, sauna use or a calorie deficit. forum
Not for a normal cuff as a toy — 20 mg still drops some people. forum
Not an ACE cough drug — different class, still a BP drug. forum
Potassium up / creatinine bump: Label labs, not optional in clinic use. trial
Pregnancy: hard no. ARBs are a known fetal-harm class. trial
NSAID + dehydration + ARB is the kidney-stack caution. trial

Updated: 2026-08-20

Evidence mix Mixed trial + community tags Full: every bullet (trial + community). Use Scan for a faster bro-science read.

↑ Back to top

Half-life & effect duration

Timing context & sources⌄

Half-life in the body

Felt duration people report

What people say 5

Doses people talk about 6

How it may feel 5

Cycles people discuss 4

Timing 4

More on what it is 6

Stacks 5

Storage notes 2

Related 5

Watch for 6

Timing context & sources